INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago
← Government Money

SCYNEXIS INC

ADVANCE THE DEVELOPMENT OF SCY-247, A NOVEL ANTIFUNGAL CURRENTLY IN PHASE 1 CLINICAL TRIALS, FOR THE TREATMENT OF INVASIVE CANDIDIASIS AND PROPHYLAXIS OF INVASIVE FUNGAL DISEASE AS ORAL AND IC FORMULA

USAspending award recordLast modified Sep 25, 2026 · verified Nov 10, 2026
  1. 01AgencyDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
  2. 02Award75A50126C00007DEFINITIVE CONTRACT
  3. 03RecipientSCYNEXIS INCNJ
  4. 04ParentSCYNEXIS INCSAM-reported parent
  5. 05SecuritySCYXExact SEC legal-name match
Obligated$18.45MCommitted by the government. Not cash paid.
OutlaysCash paid out so far.
Ceiling$213.94MBase plus all options. A maximum, not a payment.
Period of performanceSep 15, 2026 – Jul 31, 2032

Obligation timeline

Actions and modifications
No records

No obligation actions stored for this award.

Action history is fetched for the largest new contracts in each ingest.

Record

Award ID
75A50126C00007
Category
contract
Industry (NAICS)
541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Product/service (PSC)
AN13
Place of performance
NJ
Signed
Sep 25, 2026
Ingested
Nov 4, 2026
Company match
Exact SEC legal-name match · confidence 0.8